Baumhefner R - Search Results

1

Wallace William Tourtellotte, MD, PhD September 13, 1924-July 29, 2019.

Tourtellotte WG, Mishra S, Murthy K, Wasterlain C, Baumhefner R. Tourtellotte WG, et al. Among authors: baumhefner r. J Neuropathol Exp Neurol. 2019 Nov 7:nlz104. doi: 10.1093/jnen/nlz104. Online ahead of print. J Neuropathol Exp Neurol. 2019. PMID: 31697331 No abstract available.

2

In Memory of Wallace William Tourtellotte, MD, PhD (1924-2019).

Baumhefner R, Wasterlain C, Mishra S, Murthy K. Baumhefner R, et al. Ann Neurol. 2020 Feb;87(2):170-171. doi: 10.1002/ana.25659. Epub 2019 Dec 25. Ann Neurol. 2020. PMID: 31875425 No abstract available.

3

Standard Dose Weekly Intramuscular Beta Interferon-1a May Be Inadequate for Some Patients with Multiple Sclerosis: A 19-Year Clinical Experience Using Twice a Week Dosage.

Baumhefner RW, Leng M. Baumhefner RW, et al. Neurol Ther. 2022 Sep;11(3):1399-1408. doi: 10.1007/s40120-022-00377-1. Epub 2022 Jul 7. Neurol Ther. 2022. PMID: 35796951 Free PMC article.

4

Randomized study combining interferon and glatiramer acetate in multiple sclerosis.

Lublin FD, Cofield SS, Cutter GR, Conwit R, Narayana PA, Nelson F, Salter AR, Gustafson T, Wolinsky JS; CombiRx Investigators. Lublin FD, et al. Ann Neurol. 2013 Mar;73(3):327-40. doi: 10.1002/ana.23863. Epub 2013 Mar 11. Ann Neurol. 2013. PMID: 23424159 Free PMC article. Clinical Trial.

5

Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis.

Baumhefner RW, Tourtellotte WW, Syndulko K, Waluch V, Ellison GW, Meyers LW, Cohen SN, Osborne M, Shapshak P. Baumhefner RW, et al. Arch Neurol. 1990 Jan;47(1):19-26. doi: 10.1001/archneur.1990.00530010027014. Arch Neurol. 1990. PMID: 2294889

6

Copolymer 1 as therapy for multiple sclerosis: the cons.

Baumhefner RW, Tourtellotte WW, Syndulko K, Shapshak P, Osborne M, Rubinshtein G. Baumhefner RW, et al. Neurology. 1988 Jul;38(7 Suppl 2):69-72. Neurology. 1988. PMID: 3386845 Clinical Trial.

7

A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase.

Tourtellotte WW, Syndulko K, Baumhefner RW, Shapshak P, Osborne M. Tourtellotte WW, et al. Among authors: baumhefner rw. Neurology. 1988 Jul;38(7 Suppl 2):83-6. Neurology. 1988. PMID: 3386848 No abstract available.

8

Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.

Govindarajan KA, Datta S, Hasan KM, Choi S, Rahbar MH, Cofield SS, Cutter GR, Lublin FD, Wolinsky JS, Narayana PA; MRI Analysis Center at Houston; CombiRx Investigators Group. Govindarajan KA, et al. Hum Brain Mapp. 2015 Oct;36(10):3749-3760. doi: 10.1002/hbm.22875. Epub 2015 Jun 19. Hum Brain Mapp. 2015. PMID: 26096844 Free PMC article. Clinical Trial.

9

A commentary on correlates between cerebrospinal fluid gamma-globulins and magnetic resonance imaging in multiple sclerosis.

Baumhefner RW, Syndulko K, Tourtellotte WW. Baumhefner RW, et al. Arch Neurol. 1990 Aug;47(8):841-3. doi: 10.1001/archneur.1990.00530080023003. Arch Neurol. 1990. PMID: 2375687 No abstract available.

10

Multiple sclerosis intra-blood-brain-barrier IgG synthesis: effect of pulse intravenous and intrathecal corticosteroids.

Baumhefner RW, Tourtellotte WW, Syndulko K, Staugaitis A, Shapshak P. Baumhefner RW, et al. Ital J Neurol Sci. 1989 Feb;10(1):19-32. doi: 10.1007/BF02333869. Ital J Neurol Sci. 1989. PMID: 2925343

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters